The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLSDays features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Ms. Charlotte af Klercker

Program Manager Life Science, Business Sweden

29 Sep 12:00 Main Hall NLSDays Fireside Chat by Business Sweden

Dr. Gunnar Ahlberg

Chief Medical Officer , Sciety

28 Sep 13:00 Main Hall NLSInvest Rising Stars Pitches – Part 1

29 Sep 13:00 Main Hall NLSInvest Rising Stars Pitches – Part 2

Ms. Sana Alajmovic

Co-Founder & CEO, Sigrid Therapeutics

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. Ali Areffard

Disease Area Head Oncology, Bristol Myers Squibb Norway

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Dr. Georgina Askeland

Investment Associate, Hadean Ventures

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Ms. Maria Bech

CEO, EpiEndo Pharmaceuticals

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. Sonia Benhamida

Principal, Kreos Capital

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Mr. Henrik Blombersson

Co-Founder and COO, Viedoc

28 Sep 10:00 Main Hall NLSDays Fireside Chat by LINK Medical

Dr. Jana Buzkova

COO & Co-founder, NADMED

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Dr. Antonella Chadha Santuccione

Chief Medical Officer, Altoida - CEO and Co-Founder Women's Brain Project

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Mr. Stephan Christgau

Founding Partner, Eir Ventures

28 Sep 15:00 Main Hall NLSDays Fireside Chat with Back Bay Life Science Advisors

Dr. Karin Conde-Knape

Senior Vice President Global Drug Discovery, Novo Nordisk

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Mr. Gunnar Danielsson

Senior Regulatory Advisor, Link Medical Research

28 Sep 10:00 Main Hall NLSDays Fireside Chat by LINK Medical

Mr. Christopher de Souza

Director, Broadview Ventures

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. Matthias Degroote

Applied Quantum Computing Scientist, Boehringer Ingelheim

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Dr. Esmaeil Dorraji

Researcher, Institute for Cancer Research - Oslo University Hospital

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Mr. Olivier Duchamp-Giudicelli

Managing Director, NLSDays - Vice-President, SwedenBIO

28 Sep 09:15 Plenary Room NLSDays Grand Opening

29 Sep 16:00 Plenary Room NLSInvest Awards & Closing Address

Dr. Morten Egeberg

Leader SPARK Norway, University of Oslo (UiO)

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Ms. Anya Eldan

CEO, Nury Ventures

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Mr. Michael Engsig

CEO, Nykode Therapeutics

28 Sep 09:15 Plenary Room NLSDays Grand Opening

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Mr. David Eriksson

Chief Creative Officer, Mindforce Game Lab

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Dr. Sarah Fredriksson

CEO, Aqilion

28 Sep 15:00 Main Hall NLSDays Fireside Chat with Back Bay Life Science Advisors

Mr. Matthew Fujisawa

Vice President Corporate Development, Kry

29 Sep 12:00 Main Hall NLSDays Fireside Chat by Business Sweden

Dr. Armend G. Håti

CEO & Co-founder, ClexBio

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Mr. Jonathan P. Gertler

Managing Director, BioVentures MedTech Funds - Co-Founder, CEO & Managing Partner, Back Bay Life Science Advisors

28 Sep 15:00 Main Hall NLSDays Fireside Chat with Back Bay Life Science Advisors

Dr. Eva-Karin Gidlund

Head of Alliance and Innovation, NorthX

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Dr. Anna Gisselsson

Investment Manager, Almi Invest

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Dr. Ida Grundberg

Chief Scientific Officer, Olink Proteomics

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Dr. Gunnveig Grødeland

Senior Scientist and Research Group Leader, University of Oslo

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Ms. Kaisa Helminen

Chief Operating Officer, Aiforia Technologies

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Mr. Jonas Jendi

Chief Investment Officer & Head of Analysis, Industrifonden

29 Sep 12:00 Main Hall NLSDays Fireside Chat by Business Sweden

Dr. Carl Kilander

Partner, HealthCap

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Dr. Holger Kissel

Vice President Business Alliances, BioNTech

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Mr. Kristofer Klerfalk

Co-Founder & CEO, CoCreation Health Group

28 Sep 10:00 Main Hall NLSDays Fireside Chat by LINK Medical

Dr. Laura Koivusalo

CEO, StemSight

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Mr. Klaus Langhoff-Roos

CEO, StemMedical

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Ms. Frida Lawenius

Deputy Director General, SwedenBIO

29 Sep 16:00 Plenary Room NLSInvest Awards & Closing Address

Mr. Patrik Ling

Senior Analyst Healthcare, DNB Markets

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Dr. Heinz Lubenau

Chief Drug Development Officer, NEC OncoImmunity

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Dr. Jim Lund

Researcher, Research Institutes of Sweden (RISE)

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Ms. Anne Margrethe M. Platou

ESG Analyst, DNB Markets

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Ms. Hedda Magnusson

Director Clinical Operations, LINK Medical Research

28 Sep 10:00 Main Hall NLSDays Fireside Chat by LINK Medical

Ms. Eleanor Malone

Editor in Chief, Citeline

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Dr. Remy Martin

Commercial Manager, eXmoor

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Ms. Alice Mattsson

Founder, Pharmista Technologies

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Dr. Lisa Melton

Senior News Editor, Nature Biotechnology

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Maarit Merla

Head of Business Development, Forendo Pharma

Dr. Kelle Moley

Vice President Science and Public Affairs, Reproductive Medicine Maternal Health (RMMH), Ferring Pharmaceuticals

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. Philipp Mueller

Executive Director & Investment Manager, Boehringer Ingelheim Venture Fund

29 Sep 12:00 Main Hall NLSDays Fireside Chat by Business Sweden

Dr. Victor Neduva

Senior Director Discovery Research, MSD

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Cecilia Nord

Global Head of Sustainability, Sobi

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Dr. Anders Persson

Executive Director Ecosystem Strategy & Innovation, AstraZeneca

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Ms. Chelsea Ranger

Chair of NLSInvest Committee & Senior Advisor, SwedenBIO

29 Sep 16:00 Plenary Room NLSInvest Awards & Closing Address

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. João Ribas

Senior Associate, Novo Holdings

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Dr. Ditte Riber

Program Director, SPARK Denmark

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Dr. Laura Ruiz

Applications Lead, BiologIC

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Mr. Mike Ryan

Executive Vice President Europe, Eversana

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Mr. Michael Schön

Volvo Cars R&D Innovation (Open Innovation Arena), Volvo Cars

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Dr. Märta Segerdahl

Chief Medical Officer, AlzeCure Pharma

28 Sep 10:00 Main Hall NLSDays Fireside Chat by LINK Medical

Dr. Ulrica Sehlstedt

Managing Partner, Arthur D. Little

29 Sep 16:00 Plenary Room NLSInvest Awards & Closing Address

Dr. David J. Sexton

Collaboration Executive, Cell and Gene Therapy Catapult

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Mr. Philip Siberg

Founder, Coala Life

29 Sep 12:00 Main Hall NLSDays Fireside Chat by Business Sweden

Mr. Prateek Singh

CEO, Finnadvance

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. David Sonnek

CEO, Navigare Ventures

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Dr. Pasi Sorvisto

Founder & Director, SPARK Finland - Director, SPARK Europe

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Prof. Kári Stefánsson

Founder & CEO, deCODE genetics

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Dr. Britta Stenson

Program Manager Life Science, Business Sweden

29 Sep 12:00 Main Hall NLSDays Fireside Chat by Business Sweden

Ms. Helena Strigård

CEO, SwedenBIO

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Mr. Pontus Stråhlman

Partner, Voima Ventures

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Ms. Sarah Thomas

Portfolio Manager and Healthcare Analyst, BlackRock

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Ms. Diana Torgensen

Executive Director, External Innovation & Emerging Science, Organon

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Mr. Eric van der Helm

VP Scientific Affairs, SNIPR Biome

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. Maria Vistnes

Resident Doctor and Researcher in Cardiology, University of Oslo (UiO)

29 Sep 10:00 Main Hall NLSDays Fireside Chat with SPARK

Mr. Erik Wall

EMEA Sustainability Leader, Cytiva

28 Sep 12:00 Main Hall NLSDays Fireside Chat with UK Science & Innovation Network

Dr. Louise Warme

Investment Manager, Almi Invest

Ms. Iris Öhrn

Investment Advisor Life Science, Business Region Göteborg

28 Sep 13:00 Main Hall NLSInvest Rising Stars Pitches – Part 1

29 Sep 13:00 Main Hall NLSInvest Rising Stars Pitches – Part 2

Prof. Margrét Þorsteinsdóttir

Professor Pharmaceutical Sciences, University of Iceland

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease